Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031508 |
---|---|
Receipt number | R000035376 |
Scientific Title | Combination of checkpoint inhibitor and radiotherapy for recurrent gastric cancer after initial treatment with standard therapy. |
Date of disclosure of the study information | 2018/03/01 |
Last modified on | 2021/08/18 15:56:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/02/28 11:34:45 | ||
2 | Update | 2018/03/07 08:58:15 | Recruitment status |
|
3 | Update | 2018/03/07 09:00:52 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
4 | Update | 2018/08/31 15:44:54 | Organization Organization Email1 |
|
5 | Update | 2018/12/17 13:19:50 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2018/12/17 13:24:55 | Co-sponsor Co-sponsor |
|
7 | Update | 2019/04/02 10:03:44 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2019/04/02 10:04:49 | Key inclusion criteria Key inclusion criteria |
|
9 | Update | 2020/07/16 07:37:17 | Recruitment status Date of IRB Last follow-up date |
|
10 | Update | 2021/03/02 10:38:30 | Last follow-up date |
|
11 | Update | 2021/08/18 15:50:32 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Address Address Tel |
|
12 | Update | 2021/08/18 15:52:50 | Number of participants that the trial has enrolled |
|
13 | Update | 2021/08/18 15:56:21 | Recruitment status Date trial data considered complete |